Literature DB >> 24226203

Evidence for an alternatively spliced MITF exon 2 variant.

Jacinta L Simmons1, Carly J Pierce1, Glen M Boyle2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24226203     DOI： 10.1038/jid.2013.426

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  11 in total

1.  c-Kit triggers dual phosphorylations, which couple activation and degradation of the essential melanocyte factor Mi.

Authors:  M Wu; T J Hemesath; C M Takemoto; M A Horstmann; A G Wells; E R Price; D Z Fisher; D E Fisher
Journal:  Genes Dev       Date:  2000-02-01       Impact factor: 11.361

2.  MITF and cell proliferation: the role of alternative splice forms.

Authors:  Keren Bismuth; Dragan Maric; Heinz Arnheiter
Journal:  Pigment Cell Res       Date:  2005-10

3.  A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma.

Authors:  Corine Bertolotto; Fabienne Lesueur; Sandy Giuliano; Thomas Strub; Mahaut de Lichy; Karine Bille; Philippe Dessen; Benoit d'Hayer; Hamida Mohamdi; Audrey Remenieras; Eve Maubec; Arnaud de la Fouchardière; Vincent Molinié; Pierre Vabres; Stéphane Dalle; Nicolas Poulalhon; Tanguy Martin-Denavit; Luc Thomas; Pascale Andry-Benzaquen; Nicolas Dupin; Françoise Boitier; Annick Rossi; Jean-Luc Perrot; Bruno Labeille; Caroline Robert; Bernard Escudier; Olivier Caron; Laurence Brugières; Simon Saule; Betty Gardie; Sophie Gad; Stéphane Richard; Jérôme Couturier; Bin Tean Teh; Paola Ghiorzo; Lorenza Pastorino; Susana Puig; Celia Badenas; Hakan Olsson; Christian Ingvar; Etienne Rouleau; Rosette Lidereau; Philippe Bahadoran; Philippe Vielh; Eve Corda; Hélène Blanché; Diana Zelenika; Pilar Galan; François Aubin; Bertrand Bachollet; Céline Becuwe; Pascaline Berthet; Yves Jean Bignon; Valérie Bonadona; Jean-Louis Bonafe; Marie-Noëlle Bonnet-Dupeyron; Fréderic Cambazard; Jacqueline Chevrant-Breton; Isabelle Coupier; Sophie Dalac; Liliane Demange; Michel d'Incan; Catherine Dugast; Laurence Faivre; Lynda Vincent-Fétita; Marion Gauthier-Villars; Brigitte Gilbert; Florent Grange; Jean-Jacques Grob; Philippe Humbert; Nicolas Janin; Pascal Joly; Delphine Kerob; Christine Lasset; Dominique Leroux; Julien Levang; Jean-Marc Limacher; Cristina Livideanu; Michel Longy; Alain Lortholary; Dominique Stoppa-Lyonnet; Sandrine Mansard; Ludovic Mansuy; Karine Marrou; Christine Matéus; Christine Maugard; Nicolas Meyer; Catherine Nogues; Pierre Souteyrand; Laurence Venat-Bouvet; Hélène Zattara; Valérie Chaudru; Gilbert M Lenoir; Mark Lathrop; Irwin Davidson; Marie-Françoise Avril; Florence Demenais; Robert Ballotti; Brigitte Bressac-de Paillerets
Journal:  Nature       Date:  2011-10-19       Impact factor: 49.962

4.  Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma.

Authors:  Levi A Garraway; Hans R Widlund; Mark A Rubin; Gad Getz; Aaron J Berger; Sridhar Ramaswamy; Rameen Beroukhim; Danny A Milner; Scott R Granter; Jinyan Du; Charles Lee; Stephan N Wagner; Cheng Li; Todd R Golub; David L Rimm; Matthew L Meyerson; David E Fisher; William R Sellers
Journal:  Nature       Date:  2005-07-07       Impact factor: 49.962

5.  Genomic, transcriptional and mutational analysis of the mouse microphthalmia locus.

Authors:  J H Hallsson; J Favor; C Hodgkinson; T Glaser; M L Lamoreux; R Magnúsdóttir; G J Gunnarsson; H O Sweet; N G Copeland; N A Jenkins; E Steingrímsson
Journal:  Genetics       Date:  2000-05       Impact factor: 4.562

Review 6.  Melanocytes and the microphthalmia transcription factor network.

Authors:  Eiríkur Steingrímsson; Neal G Copeland; Nancy A Jenkins
Journal:  Annu Rev Genet       Date:  2004       Impact factor: 16.830

7.  Mitf-Mdel, a novel melanocyte/melanoma-specific isoform of microphthalmia-associated transcription factor-M, as a candidate biomarker for melanoma.

Authors:  Yixiang Wang; Soroosh Radfar; Suhu Liu; Adam I Riker; Hung T Khong
Journal:  BMC Med       Date:  2010-02-17       Impact factor: 8.775

8.  Microphthalmia-associated transcription factor gene amplification in metastatic melanoma is a prognostic marker for patient survival, but not a predictive marker for chemosensitivity and chemotherapy response.

Authors:  Selma Ugurel; Roland Houben; David Schrama; Heike Voigt; Marc Zapatka; Dirk Schadendorf; Eva B Bröcker; Jürgen C Becker
Journal:  Clin Cancer Res       Date:  2007-11-01       Impact factor: 12.531

9.  The role of MITF phosphorylation sites during coat color and eye development in mice analyzed by bacterial artificial chromosome transgene rescue.

Authors:  Georg L Bauer; Christian Praetorius; Kristín Bergsteinsdóttir; Jón H Hallsson; Bryndís K Gísladóttir; Alexander Schepsky; Deborah A Swing; T Norene O'Sullivan; Heinz Arnheiter; Keren Bismuth; Julien Debbache; Colin Fletcher; Søren Warming; Neal G Copeland; Nancy A Jenkins; Eiríkur Steingrímsson
Journal:  Genetics       Date:  2009-07-27       Impact factor: 4.562

10.  Frequent mutations in the MITF pathway in melanoma.

Authors:  Julia C Cronin; John Wunderlich; Stacie K Loftus; Todd D Prickett; Xiaomu Wei; Katie Ridd; Swapna Vemula; Allison S Burrell; Neena S Agrawal; Jimmy C Lin; Carolyn E Banister; Phillip Buckhaults; Steven A Rosenberg; Boris C Bastian; William J Pavan; Yardena Samuels
Journal:  Pigment Cell Melanoma Res       Date:  2009-04-29       Impact factor: 4.693
View more
  1 in total

1.  Temperature-sensitive splicing of mitfa by an intron mutation in zebrafish.

Authors:  Zhiqiang Zeng; Stephen L Johnson; James A Lister; E Elizabeth Patton
Journal:  Pigment Cell Melanoma Res       Date:  2014-12-29       Impact factor: 4.693
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.